Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Iwami

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Cell Reports|January 31, 2024
Two-step evolution of HIV-1 budding system leading to pandemic in the human populationYoriyuki Konno, Keiya Uriu, Takayuki Chikata, et al.
Antiviral Research|July 7, 2022
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, et al.
Science Translational Medicine|July 2, 2025
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the CongoTakara Nishiyama, Fuminari Miura, Yong Dam Jeong, et al.
BMC Medicine|August 12, 2025
Evaluating the effectiveness of international travel controls to identify MPXV-infected travelers: a simulation studyKeisuke Ejima, Yuqian Wang, Akira Endo, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
Iscience|April 5, 2021
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentHirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.
PLOS Digital Health|May 3, 2024
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general populationNaotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
Microbiology Spectrum|May 4, 2023
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19Taiga Miyazaki, Naoki Hosogaya, Yuri Fukushige, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Cell Reports|January 31, 2024
Two-step evolution of HIV-1 budding system leading to pandemic in the human populationYoriyuki Konno, Keiya Uriu, Takayuki Chikata, et al.
Antiviral Research|July 7, 2022
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, et al.
Science Translational Medicine|July 2, 2025
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the CongoTakara Nishiyama, Fuminari Miura, Yong Dam Jeong, et al.
BMC Medicine|August 12, 2025
Evaluating the effectiveness of international travel controls to identify MPXV-infected travelers: a simulation studyKeisuke Ejima, Yuqian Wang, Akira Endo, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
Iscience|April 5, 2021
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentHirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.
PLOS Digital Health|May 3, 2024
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general populationNaotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
Microbiology Spectrum|May 4, 2023
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19Taiga Miyazaki, Naoki Hosogaya, Yuri Fukushige, et al.
Pageof 14